SSA Swiss Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-126,369
Closed -$3.52M – 110
2026
Q1
$3.52M Hold
126,369
– – 1.63% 22
2025
Q4
$3.16M Hold
126,369
– – 1.47% 29
2025
Q3
$3.22M Hold
126,369
– – 1.5% 28
2025
Q2
$3.2M Buy
126,369
+14,900
+13% +$347K 1.54% 30
2025
Q1
$2.83M Buy
+111,469
New +$2.92M 1.45% 32

Other funds holding PFE

SSA Swiss Advisors's PFE Position: Q2 2026 in Review

SSA Swiss Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 126,369 shares — an estimated $3.52M sold.

SSA Swiss Advisors first reported a position in PFE in Q1 2025 and held it in 5 quarters. The position peaked at $3.52M in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • SSA Swiss Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • SSA Swiss Advisors sold 126,369 Pfizer shares in Q2 2026, an estimated $3.52M.
  • SSA Swiss Advisors first reported a position in Pfizer in Q1 2025 and held it in 5 quarters.
  • SSA Swiss Advisors's Pfizer position peaked at $3.52M in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on SSA Swiss Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.